ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,067.00
-1.24%
S&P ASX All Technology
3,766.30
-0.74%
Brent Oil
72.72
0.00%
US Dollar vs AUD
1.59949
0.00%
Bitcoin
97,200.19
-0.58%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Argen X SE (ARGX) Share Price

Argen X SE

Argen X SE (ARGX)

argenx SE
604.60
4.80
(0.80%)
Closed 22 December 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
604.60
Bid
587.00
Offer
610.00
Volume
169,990
586.40 Day's Range 606.40
271.00 52 Week Range 613.00
Market Cap
35.789B
Previous Close
599.80
Open
597.80
Last Trade
100
@
604.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
58,304
Shares Outstanding
59,194,000
Dividend Yield
-
PE Ratio
-121.30
Earnings Per Share (EPS)
-4.98
Revenue
1.27B
Net Profit
-295.05M

About Argen X SE

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.argenx.com
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 599.80 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 613.00 €.

Argen X currently has 59,194,000 shares in issue. The market capitalisation of Argen X is 35.50 € billion. Argen X has a price to earnings ratio (PE ratio) of -121.30.

Ask ADVFN Intelligence (AI)

ARGX Latest News

More News

argenx to Present at Upcoming Investor Conferences

November 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

26 November 2024
GlobeNewswire Inc.

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

20 November 2024
GlobeNewswire Inc.

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China  Second VYVGART Hytrulo indication approved in China  November 11, 2024 – 7:30am ET  Amsterdam, the Netherlands— argenx...

11 November 2024
GlobeNewswire Inc.

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

05 November 2024
GlobeNewswire Inc.

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

31 October 2024
GlobeNewswire Inc.

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

24 October 2024
GlobeNewswire Inc.

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

15 October 2024
GlobeNewswire Inc.

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

19 September 2024
GlobeNewswire Inc.

argenx to Present at Upcoming Investor Conferences

August 28, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

28 August 2024
GlobeNewswire Inc.

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

25 July 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
123.64.06196213425581613577.462076599.54503963DE
433.65.88441330998571613569.661368589.97939387DE
12129.927.3646513588474.7613467.658304546.24457958DE
26251.471.1778029445353.2613352.963420488.46246358DE
52321.6113.63957597228361327162234420.51209553DE
156285.489.4110275689319.2613224.165339376.08755572DE
260455.1304.414715719149.561393.0574489297.94845287DE

ARGX - Frequently Asked Questions (FAQ)

What is the current Argen X share price?
The current share price of Argen X is 604.60 €
How many Argen X shares are in issue?
Argen X has 59,194,000 shares in issue
What is the market cap of Argen X?
The market capitalisation of Argen X is EUR 35.5B
What is the 1 year trading range for Argen X share price?
Argen X has traded in the range of 271.00 € to 613.00 € during the past year
What is the PE ratio of Argen X?
The price to earnings ratio of Argen X is -121.3
What is the cash to sales ratio of Argen X?
The cash to sales ratio of Argen X is 28.21
What is the reporting currency for Argen X?
Argen X reports financial results in USD
What is the latest annual turnover for Argen X?
The latest annual turnover of Argen X is USD 1.27B
What is the latest annual profit for Argen X?
The latest annual profit of Argen X is USD -295.05M
What is the registered address of Argen X?
The registered address for Argen X is LAARDERHOOGTWEG 25, AMSTERDAM, NORTH HOLLAND, 1101 EB
What is the Argen X website address?
The website address for Argen X is www.argenx.com
Which industry sector does Argen X operate in?
Argen X operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMBSZTME Pharma NV
0.02 €
(185.71%)
132.5k
MLGEQGentlemen S Equity SA
0.0175 €
(118.75%)
1.14k
ALCYBCybergun
0.0002 €
(100.00%)
17.54M
MLAAHAmatheon Agri Holding NV
0.0185 €
(54.17%)
40.1k
ALARFAdeunis
0.94 €
(28.77%)
5.27k
MLSMLSmalto
0.0125 €
(-37.50%)
2.34k
MLFTIFrance Tourisme Immobilier
0.025 €
(-35.90%)
56.77k
CNVCnova NV
0.209 €
(-19.62%)
26.38k
MLWEAWeaccess Group
0.382 €
(-16.96%)
5.95k
ALEUPEuroplasma
0.0353 €
(-15.95%)
3.16M
ATOAtos SE
0.0021 €
(0.00%)
2.71B
BCPBanco Comercial Portugues SA
0.4493 €
(-0.69%)
66.54M
ALHGLouis Hachette Group
1.3342 €
(4.87%)
52.04M
KPNKoninklijke KPN NV
3.509 €
(-1.21%)
26.9M
VIVVivendi SE
2.51 €
(2.41%)
26.39M

Discussion

View Full Feed
al44 al44 4 minutes ago
Romance, RICO, and road trips: Fani Willis’s justice junket

By Charlton Allen


Fulton County faces the daunting task of rebuilding trust in its justice system. Whether it succeeds remains to be seen.

In Fulton County, Georgia, justice has taken a
Hoskuld Hoskuld 4 minutes ago
Hosai, that depends on how the number was arrived at by Google's AI. Impact factor is usually a calculation based on the number of times papers in the journal were cited by researchers over a 2 year period - which means impact factor can change significantly from year to year. I don't know if 9.2
AVXL
Johnnycombat10 Johnnycombat10 4 minutes ago
Outing bashing with the only limitations on their theory of speculation about PHIL is only speculation and not truth.
PHIL
glenn1919 glenn1919 5 minutes ago
IMRX........SLRX....MYNZ.......SRFM.........RDZN.......https://stockcharts.com/h-sc/ui?s=IMRX&p=D&yr=0&mn=2&dy=12&id=p84071410134
IMRX MYNZ RDZN
TheHound TheHound 5 minutes ago
News! https://www.globenewswire.com/fr/news-release/2016/12/22/901271/0/en/Cellceutix-Wishes-Shareholders-Happy-Holidays-Prepares-for-2017-Focused-on-Partnerships.html




Albeit old news. Very old news.
IPIX
blackhawks blackhawks 5 minutes ago
But, but, the cost of eggs!

U.S. economic growth revised up to 3.1% in third quarter
Source: axios

The revision suggests 2024 was yet another shocker year in which the U.S. economy surprised to the upside, as other major nations grappled with sluggish growth.
Investor082 Investor082 5 minutes ago
Not without reimbursement and hiring. No one trusts the lying crew.
NWBO
Backstabbed Backstabbed 6 minutes ago
You can't get delisted from OTC! wow... they just turn EM until they file 
VHAI
MrSmith18 MrSmith18 6 minutes ago
In my opinion, GS is definitely prepping something. Web sites don't come down unless the owner stops paying, (which I doubt happened here) or the owner, GS, took it down. Knowing GS's MO of antagonizing everyone with an element of surprise, my guess is that he's has a very big deal in the works. By
FORW GVSI SRNW
blackhawks blackhawks 6 minutes ago
But, but, the cost of eggs!

U.S. economic growth revised up to 3.1% in third quarter
Source: axios

The revision suggests 2024 was yet another shocker year in which the U.S. economy surprised to the upside, as other major nations grappled with sluggish growth.
Timing101 Timing101 6 minutes ago
Here you go
--
$EARI Very, Very Interesting. Leadership Change and the new Person Robert Morrissey (see the link(s) I always provide for any to research) has his company BRN (https://bigrednose.com)
Robert Morrissey LinkedIn File
https://linkedin.com/in/robert-morriss
EARI
Mr. Dragon Mr. Dragon 6 minutes ago
There are only two things I can't figure out about this scam. First, why on earth would anyone invest in a ticker with 46,873,940,565 OS. Second, why the gangster hasn't pulled the RS trick yet?
PHIL
blackhawks blackhawks 7 minutes ago
But, but, the cost of eggs!

U.S. economic growth revised up to 3.1% in third quarter
Source: axios

The revision suggests 2024 was yet another shocker year in which the U.S. economy surprised to the upside, as other major nations grappled with sluggish growth.
zakattack zakattack 7 minutes ago
My question is why not go current now update start mining cause it take a year to go to market to realize gains ? Why wait with regulations laying and gold ar highs why not start now? It leaves me skeptical that there is any? Why is he waiting
GNCP
blackhawks blackhawks 7 minutes ago
But, but, the cost of eggs!

U.S. economic growth revised up to 3.1% in third quarter
Source: axios

The revision suggests 2024 was yet another shocker year in which the U.S. economy surprised to the upside, as other major nations grappled with sluggish growth.
al44 al44 8 minutes ago
Barreling toward a shutdown, KJP announces $1 billion for… rainforests in South America

By Olivia Murray

We’re barreling toward a government shutdown (go, go go!) because Congress wants to stuff their faces like pigs at the trough, and pesky dissenters like President Tr
glenn1919 glenn1919 8 minutes ago
HOVR......VVPR.......PSNY.......PSNL......https://stockcharts.com/h-sc/ui?s=VVPR&p=D&yr=0&mn=2&dy=12&id=p84071410134
HOVR PSNL PSNY
investisseur101 investisseur101 9 minutes ago
I was hoping that you never answer me.. I know what i own..i dont need negative in my life with no beliver( i block all bashers who answer me) .. good luck..i cant imagine on day loose my precious time on a stock that i dont like..
HMBL
Shawonsarker84 Shawonsarker84 9 minutes ago
It took us almost 5 years to get that patent approved.

"A provisional patent application was first filed on January 7, 2020, and the earliest publication date was July 8, 2021. The lead author of the patent is HUMBL CEO, Brian McLaren Foote, with co-author contributions from Adam Wol
HMBL
spartex spartex 10 minutes ago
Very cool at the end of the Lebby interview on future options using polymer was in "optical computing". As well as quantum mentioned too.
LWLG
chipboarder chipboarder 10 minutes ago
Oura’s first generation ring was launched in 2015 so they are soon to be 10 years old. given that kind of head start, much will depend upon product differentiation afforded by the RF technology….if RF is only another way to accomplish the same measurements with the same accuracy, the customers hav
LQMT
pos_stock_hoarder pos_stock_hoarder 10 minutes ago
They'll keep paying him to keep stomping on his elfin feet?!
x993231 x993231 11 minutes ago
Hopefully you did it in a tax-free retirement account, taxes are always a big part of my strategy. In the event of a takeover this year I like the idea of long-term cap tax rate of 20% vs short term tax rate of 37%. Plus 6.6% in my state.

Xster Get er Done Gang is in the house.
LWLG
Sideem Sideem 11 minutes ago
Yes it is. Good luck and Happy Holidays to you as well.
BB

Your Recent History

EU
ARGX
Argen X
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads